Drug Shortage Report for TEVA-PREGABALIN

Last updated on 2018-05-11 History
Report ID 42573
Drug Identification Number 02361183
Brand name TEVA-PREGABALIN
Common or Proper name PREGABALIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 75MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-03-13
Estimated end date 2018-03-21
Actual end date 2018-04-15
Shortage status Resolved
Updated date 2018-05-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-05-11 French Compare
v4 2018-05-11 English Compare
v3 2018-03-14 English Compare
v2 2018-03-13 French Compare
v1 2018-03-13 English Compare